We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CRI:NYSECarter's, Inc. Analysis

Data as of 2026-05-22 - not real-time

$37.56

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Carter's posted Q1 FY2026 sales up 8.1% YoY to $681.1 million, beating consensus and delivering non‑GAAP EPS of $0.39. The stock trades at $37.56, roughly 8% below the analyst median target of $40.5, implying modest upside. However, the DCF fair value of $27.8 suggests the market may be pricing in premium expectations. Technicals show the price comfortably above the 20‑day and 50‑day SMAs (35.34 and 35.59), with a bullish MACD histogram and an RSI of 58, indicating neutral‑to‑positive momentum. Volume has been trending down, and the 30‑day volatility is elevated at 58%, flagging higher short‑term price swings. The company’s dividend yield of 2.66% and a payout ratio of 40% are supported by $95 million of free cash flow and a solid cash balance of $473 million. Debt remains high, with a debt‑to‑equity of 129%, but the leverage is offset by consistent operating cash flow and a ROE of 10.2%. Gross margin sits at 44.7% and operating margin at 4.2%, reflecting stable profitability in a competitive apparel segment. The beta of roughly 1.2 and the consumer‑cyclical nature of the business add medium‑to‑high market sensitivity. The current support at $32.16 and resistance near $39.47 give a clear trading range for the near term. Overall, the blend of earnings beat, dividend appeal, and modest target upside supports a positive bias, while valuation and leverage temper enthusiasm. Investors should weigh the short‑term upside against the elevated volatility and long‑term debt profile before adjusting positions.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Q1 earnings beat expectations
  • Price above 20‑day and 50‑day SMAs with bullish MACD
  • Support level provides downside cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst median target suggests ~7% upside
  • Sustainable dividend yield of 2.66%
  • Revenue growth of 8% YoY

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High debt‑to‑equity ratio raises leverage risk
  • Valuation split between DCF undervaluation and market premium
  • Consumer‑cyclical exposure adds sector volatility

Key Metrics & Analysis

Financial Health

Revenue Growth8.10%
Profit Margin3.07%
P/E Ratio15.1
ROE10.20%
ROA3.80%
Debt/Equity128.85
P/B Ratio1.5
Op. Cash Flow$177.4M
Free Cash Flow$95.2M

Technical Analysis

TrendNeutral
RSI58.2
Support$32.16
Resistance$39.47
MA 20$35.34
MA 50$35.59
MA 200$33.01
MACDBullish
VolumeDecreasing
Fear & Greed Index91.5

Valuation

Fair Value$27.81
Target Price$40.67
Upside/Downside8.27%
GradeFair
TypeBlend
Dividend Yield2.66%

Risk Assessment

Beta1.20
Volatility58.54%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.